Name: NURS6630 Pharmacology Final Exam With Answers (76 Solved Questions)
Brand: Walden University
Price: 3 USD
Availability: InStock
Author: Emily Jackson

NURS6630 Final Exam: Walden University
QUESTION 1
What will the PMHNP most likely prescribe to a patient with psychotic aggression who needs to
manage the top-down cortical control and the excessive drive from striatal hyperactivity?
A. Stimulants B. Antidepressants C. Antipsychotics D. SSRIs
QUESTION 2
The PMHNP is selecting a medication treatment option for a patient who is exhibiting psychotic
behaviors with poor impulse control and aggression. Of the available treatments, which can help
temper some of the adverse effects or symptoms that are normally caused by D2 antagonism?
A. First-generation, conventional antipsychotics B. First-generation, atypical antipsychotics C.
Second-generation, conventional antipsychotics D. Second-generation, atypical antipsychotics
QUESTION 3
The PMHNP is discussing dopamine D2 receptor occupancy and its association with aggressive
behaviors in patients with the student. Why does the PMHNP prescribe a standard dose of
atypical antipsychotics?
A. The doses are based on achieving 100% D2 receptor occupancy. B. The doses are based on
achieving a minimum of 80% D2 receptor occupancy. C. The doses are based on achieving
60% D2 receptor occupancy. D. None of the above.
lOMoARcPSD|13778330

QUESTION 4
Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the
patient with psychosis and aggression?
A. There is too high a risk of serious adverse side effects. B. It can exaggerate the psychotic
symptoms. C. Clozapine (Clozaril) should not be used as high-dose monotherapy. D. There is no
documentation that clozapine (Clozaril) is effective for patients who are violent.
QUESTION 5
The PMHNP is caring for a patient on risperidone (Risperdal). Which action made by the
PMHNP exhibits proper care for this patient?
A. Explaining to the patient that there are no risks of EPS B. Prescribing the patient 12 mg/dail
C. Titrating the dose by increasing it every 5–7 days D. Writing a prescription for a higher
dose of oral risperidone (Risperdal) to achieve high D2 receptor occupancy
QUESTION 6
The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target aggressive and
impulsive symptoms by decreasing dopaminergic neurotransmission. Which mood stabilizer will
the PMHNP select? A. Lithium (Lithane) B. Phenytoin (Dilantin) C. Valproate (Depakote) D.
Topiramate (Topamax)
lOMoARcPSD|13778330

QUESTION 7
The parents of a 7-year-old patient with ADHD are concerned about the effects of stimulants on
their child. The parents prefer to start pharmacological treatment with a non-stimulant. Which
medication will the PMHNP will most likely prescribe?
A. Strattera B. Concerta C. Daytrana D. Adderall
QUESTION 8
8 The PMHNP understands that slow-dose extended release stimulants are most appropriate for
which patient with ADHD?
A. 8-year-old patient B. 24-year-old patient C. 55-year-old patient D. 82-year-old patient
QUESTION 9
A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What should the
PMHNP include when discussing the side effects with the patient?
A. The formulation can have delayed actions when taken with food. B. Sedation can be a
common side effect of the drug. C. The medication can affect your blood pressure. D. This
drug does not cause any dependency.
QUESTION 10
The PMHNP is teaching parents about their child’s new prescription for Ritalin. What will the
PMHNP include in the teaching?
lOMoARcPSD|13778330

A. The second dose should be taken at lunch. B. There are no risks for insomnia. C. There is
only one daily dose, to be taken in the morning. D. There will be continued effects into the
evening.
QUESTION 11
A young patient is prescribed Vyvanse. During the follow-up appointment, which comment made
by the patient makes the PMHNP think that the dosing is being done incorrectly?
A. “I take my pill at breakfast.” B. “I am unable to fall asleep at night.” C. “I feel okay all day
long.” D. “I am not taking my pill at lunch.”
QUESTION 12
A 14-year-old patient is prescribed Strattera and asks when the medicine should be taken. What
does the PMHNP understand regarding the drug’s dosing profile?
A. The patient should take the medication at lunch. B. The patient will have one or two doses a
day. C. The patient will take a pill every 17 hours. D. The dosing should be done in the morning
and at night.
QUESTION 13
The PMHNP is meeting with the parents of an 8-year-old patient who is receiving an initial
prescription for D-amphetamine. The PMHNP demonstrates appropriate prescribing practices
when she prescribes the following dose:
A. The child will be prescribed 2.5 mg. B. The child will be prescribed a 10-mg tablet. C. The
child’s dose will increase by 2.5 mg every other week. D. The child will take 10–40 mg, daily.
lOMoARcPSD|13778330

QUESTION 14
A patient is being prescribed bupropion and is concerned about the side effects. What will the
PMHNP tell the patient regarding bupropion?
A. Weight gain is not unusual. B. Sedation may be common. C. It can cause cardiac
arrhythmias. D. It may amplify fatigue.
QUESTION 15
Which patient will receive a lower dose of guanfacine?
A. Patient who has congestive heart failure B. Patient who has cerebrovascular disease C. Patient
who is pregnant D. Patient with kidney disease
QUESTION 16
An 18-year-old female with a history of frequent headaches and a mood disorder is prescribed
topiramate (Topamax), 25 mg by mouth daily. The PMHNP understands that this medication is
effective in treating which condition(s) in this patient?
A. Migraines B. Bipolar disorder and depression C. Pregnancy-induced depression D. Upper
back pain
QUESTION 17
The PMHNP is treating a patient for fibromyalgia and is considering prescribing milnacipran
(Savella). When prescribing this medication, which action is the PMHNP likely to choose?
lOMoARcPSD|13778330

Loading page 6...

A. Monitor liver function every 6 months for a year and then yearly thereafter. B. Monitor
monthly weight. C. Split the daily dose into two doses after the first day. D. Monitor for
occult blood in the stool.
QUESTION 18
The PMHNP is assessing a patient she has been treating with the diagnosis of chronic pain.
During the assessment, the patient states that he has recently been having trouble getting to sleep
and staying asleep. Based on this information, what action is the PMHNP most likely to take?
A. Order hydroxyzine (Vistaril), 50 mg PRN or as needed B. Order zolpidem (Ambien), 5mg
at bedtime C. Order melatonin, 5mg at bedtime D. Order quetiapine (Seroquel), 150 mg at
bedtime
QUESTION 19
The PMHNP is assessing a female patient who has been taking lamotrigine (Lamictal) for
migraine prophylaxis. After discovering that the patient has reached the maximum dose of this
medication, the PMHNP decides to change the patient’s medication to zonisamide (Zonegran). In
addition to evaluating this patient’s day-to-day activities, what should the PMHNP ensure that
this patient understands?
A. Monthly blood levels must be drawn. B. ECG monitoring must be done once every 3 months.
C. White blood cell count must be monitored weekly. D. This medication has unwanted side
effects such as sedation, lack of coordination, and drowsiness.
QUESTION 20
lOMoARcPSD|13778330

Loading page 7...

A patient recovering from shingles presents with tenderness and sensitivity to the upper back. He
states it is bothersome to put a shirt on most days. This patient has end stage renal disease
(ESRD) and is scheduled to have hemodialysis tomorrow but states that he does not know how
he can lie in a recliner for 3 hours feeling this uncomfortable. What will be the PMHNP’s
priority?
A. Order herpes simplex virus (HSV) antibody testing B. Order a blood urea nitrogen (BUN) and
creatinine STAT C. Prescribe lidocaine 5% D. Prescribe hydromorphone (Dilaudid) 2mg
QUESTION 21
The PMHNP prescribed a patient lamotrigine (Lamictal), 25 mg by mouth daily, for nerve pain 6
months ago. The patient suddenly presents to the office with the complaint that the medication is
no longer working and complains of increased pain. What action will the PMHNP most likely
take?
A. Increase the dose of lamotrigine (Lamictal) to 25 mg twice daily. B. Ask if the patient has
been taking the medication as prescribed. C. Order gabapentin (Neurontin), 100 mg three times a
day, because lamotrigine (Lamictal) is no longer working for this patient. D. Order a complete
blood count (CBC) to assess for an infection.
QUESTION 22
An elderly woman with a history of Alzheimer’s disease, coronary artery disease, and myocardial
infarction had a fall at home 3 months ago that resulted in her receiving an open reduction
internal fixation. While assessing this patient, the PMHNP is made aware that the patient
continues to experience mild to moderate pain. What is the PMHNP most likely to do?
lOMoARcPSD|13778330

Loading page 8...

NURS6630 Pharmacology Final Exam With Answers (76 Solved Questions)

Study Now!

Document Details

Related Documents

2021 NURS6630 Psychopathology Final Exam With Answers (76 Solved Questions)

NURS6630 Mental Health Mid term Exam Final Week 6 With Answers (75 Solved Questions)

2019 NURS6630 Pharmacology Week 11 Final Exam With Answers (76 Solved Questions)

2021 NURS6630 Psychopharmacology Midterm Exam With Answers (75 Solved Questions)

2021 NURS6630 Walden University Psychopharmacologic Midterm Exam With Answers (76 Solved Questions)

2021 NURS6630 Walden University Psychopathology Mid term Exam With Answers (76 Solved Questions)

2020 NURS6630 Walden University Pharmacology Final Exam Version 1 With Answers (76 Solved Questions)

The Evolution of Nursing Science: Key Theories and Their Impact on Patient Care

Pediatric Gastrointestinal Disorders: Pathophysiology, Clinical Manifestations, Treatments, and Nursing Management

NUR/443 Cost and Effects of Performance Feedback and Nurse Case Management

Company

Explore

Study Tools